This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: University of Liverpool, Johns Hopkins University. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019-2022
Title: James Hobson: Innovator in Pharmaceutical Compositions
Introduction
James Hobson is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of pharmaceutical compositions, holding a total of 2 patents. His work focuses on enhancing drug delivery systems through innovative formulations.
Latest Patents
Hobson's latest patents include advancements in prodrug compositions and nanoemulsions. The prodrug compositions patent provides a composition comprising nanoparticles of prodrugs of certain pharmaceutically active agents, wherein the nanoparticles are dispersed within a carrier material. This invention also outlines processes for the making of these compositions. The nanoemulsions patent describes an oil-in-water emulsion that includes a non-gelled branched polymer as an emulsifier. This emulsifier has alkyl chain terminations of 5 carbon atoms or more, facilitating the carrying of hydrophobic materials within aqueous systems to enhance oral drug delivery.
Career Highlights
Throughout his career, James Hobson has worked with prestigious institutions such as the University of Liverpool and Johns Hopkins University. His research has focused on developing innovative solutions to improve drug delivery mechanisms, showcasing his commitment to advancing pharmaceutical science.
Collaborations
Hobson has collaborated with notable colleagues, including Andrew Owen and Steven Paul Rannard. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
James Hobson's contributions to pharmaceutical innovations through his patents reflect his dedication to improving drug delivery systems. His work continues to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile